In summary, using a highly precise and quantitative tool for detecting epigenetic changes in clinical samples of HCC and corresponding non-cancerous liver tissues, the present study identified that the methylation level of the APC promoter in HCC tissues was significantly higher than in paracancerous liver tissues. The gene discussed is APC; the disease is hepatocellular carcinoma.